BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/10/2022 12:53:43 PM | Browse: 633 | Download: 1544
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 72540
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia
Manuscript Source Unsolicited Manuscript
All Author List Nan-Jun Wang, Ning-Li Chai, Xiao-Wei Tang, Long-Song Li, Wen-Gang Zhang and En-Qiang Linghu
Funding Agency and Grant Number
Funding Agency Grant Number
National Key R&D Program of China 2016YFC1303601
Corresponding Author En-Qiang Linghu, MD, PhD, Chief Doctor, Chief Physician, Director, Director, Professor, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. linghuenqiang@vip.sina.com
Key Words Endoscopic radiofrequency ablation; Gastric low-grade intraepithelial neoplasia; Clinical efficacy; Prognostic risk factors
Core Tip This is a retrospective study to explore the efficacy and prognostic risk factors of radiofrequency ablation (RFA) for gastric low-grade intraepithelial neoplasia (LGIN). The curative rates of endoscopic RFA for gastric LGIN at 3 mo, 6 mo, and 1-5 years after the operation were 93.3%, 92.8%, 91.5%, 90.3%, 88.5%, 85.7%, and 83.3%, respectively. Multivariate analyses revealed that Helicobacter pylori infection and disease duration > 1 year had a significant effect on the curative rate. No serious complications occurred after RFA in all 198 patients. RFA was safe and effective for gastric LGIN during long-term follow-up.
Publish Date 2022-03-10 12:08
Citation Wang NJ, Chai NL, Tang XW, Li LS, Zhang WG, Linghu EQ. Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia. World J Gastrointest Oncol 2022; 14(3): 724-733
URL https://www.wjgnet.com/1948-5204/full/v14/i3/724.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i3.724
Full Article (PDF) WJGO-14-724.pdf
Full Article (Word) WJGO-14-724.docx